Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00855855 · ClinicalTrials.gov registry record
Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
A clinical trial, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- 20,830
- Enrollment target
NCT00855855: Completed study, sponsored by Sanofi Pasteur, a Sanofi Company.
NCT00855855 is a clinical trial that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 20,830 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00855855 has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- 20,830 participants
- Enrollment target
Study Summary
To monitor the occurrence of invasive Hib disease over time and to determine product-specific rates of invasive Hib disease within the monitored population.
Interventions
- BIOLOGICAL DTaP-IPV/Hib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,830 participants |
| Start Date | 2009-02 |
| Est. Completion | 2014-12 |
What the finished NCT00855855 record still lists
NCT00855855 is an observational study that tracks outcomes without assigning an intervention. Its 20,830 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which DTaP-IPV/Hib is the first listed.
NCT00855855 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00855855 about?
NCT00855855 is a clinical study titled "Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease". To monitor the occurrence of invasive Hib disease over time and to determine product-specific rates of invasive Hib disease within the monitored population.
What is the current status of trial NCT00855855?
This trial is currently completed. The enrollment target is 20,830 participants. The study started on 2009-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00855855?
The interventions under investigation include: DTaP-IPV/Hib (BIOLOGICAL).
Who is sponsoring clinical trial NCT00855855?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07213531 · 21,000 participants
Enhanced Valves Interventions and Safe AI Generated End Results
- NCT06062342 · 20,400 participants · NA
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia